eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Documenthome » Applications for Food and Drug Administration Approval to Market New Drug: Revision of Postmarketing Reporting Requirements; Discontinuance

Applications for Food and Drug Administration Approval to Market New Drug: Revision of Postmarketing Reporting Requirements; Discontinuance

Document ID: FDA-2011-N-0898-0001

Comments

Total: 12
American Society of Health-System Pharmacists (ASHP) - Comment
Posted : 03/01/2012     ID ：FDA-2011-N-0898-0003     Agency : FDA

Feb 17,2012 11:59 PM ET
American Hospital Association - Comment
Posted : 03/01/2012     ID ：FDA-2011-N-0898-0004     Agency : FDA

Feb 17,2012 11:59 PM ET
Colon Cancer Alliance - Comment
Posted : 03/01/2012     ID ：FDA-2011-N-0898-0005     Agency : FDA

Feb 17,2012 11:59 PM ET
Academy of Managed Care Pharmacy (AMCP) - Comment
Posted : 03/01/2012     ID ：FDA-2011-N-0898-0006     Agency : FDA

Feb 17,2012 11:59 PM ET
AstraZeneca - Comment
Posted : 03/01/2012     ID ：FDA-2011-N-0898-0007     Agency : FDA

Feb 17,2012 11:59 PM ET
Express Scripts - Comment
Posted : 03/01/2012     ID ：FDA-2011-N-0898-0008     Agency : FDA

Feb 17,2012 11:59 PM ET
American Society of Hematology (ASH) - Comment
Posted : 03/01/2012     ID ：FDA-2011-N-0898-0009     Agency : FDA

Feb 17,2012 11:59 PM ET
Trinity Health - Comment
Posted : 03/01/2012     ID ：FDA-2011-N-0898-0010     Agency : FDA

Feb 17,2012 11:59 PM ET
American Academy of Pediatrics - Comment
Posted : 03/01/2012     ID ：FDA-2011-N-0898-0011     Agency : FDA

Feb 17,2012 11:59 PM ET
Pharmaceutical Research and Manufacturers of America (PhRMA) - Comment
Posted : 03/01/2012     ID ：FDA-2011-N-0898-0012     Agency : FDA

Feb 17,2012 11:59 PM ET
Pfizer Inc. - Comment
Posted : 03/01/2012     ID ：FDA-2011-N-0898-0013     Agency : FDA

Feb 17,2012 11:59 PM ET
Pharmaceutical Research and Manufacturers of America (PhRMA) - Comment
Posted : 03/27/2012     ID ：FDA-2011-N-0898-0014     Agency : FDA

Feb 17,2012 11:59 PM ET